UK government responds to bioscience R&D (research and development) concerns
This article was originally published in Clinica
Executive Summary
The UK House of Commons' Science and Technology Committee (STC) has published the government's response to warnings surrounding the "unacceptably high" failure rate for new bioscience R&D business ventures.